
Daniel M. Huse, MA
Advertisement
Articles by Daniel M. Huse, MA
Advertisement
Latest Updated Articles
Impact of Leflunomide Versus Biologic Agents on the Costs of Care for Rheumatoid Arthritis in a Managed Care PopulationPublished: May 1st 2002 | Updated:
Use of Managed Care Claims Data in the Risk Assessment of Venous Thromboembolism in OutpatientsPublished: January 1st 2002 | Updated:
Outpatient Treatment of Venous Thromboembolism with Low-Molecular-Weight Heparin: An Economic EvaluationPublished: January 1st 2002 | Updated:
Anti-inflammatory Therapy Reduces Total Costs of Asthma Care Compared with Bronchodilation: The Asthma Outcomes RegistryPublished: September 1st 2000 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
5



